The ability to differentiate the types of pain affiliated with rheumatic diseases can help rheumatologists better diagnose and treat patients
Search results for: inflammation
ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints
Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease
ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus
Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE
Molecular Analysis Reveals Potential Treatment Window for Systemic Juvenile Idiopathic Arthritis
In patients with simultaneous systemic and arthritic components of systemic juvenile idiopathic arthritis (SJIA), these components appear to be related mechanistically. Moreover, the inflammatory pathways of SJIA appear to be distinct from those seen in polyarticular JIA.
Foundation Researcher Studies Role of IL-17 in Rheumatoid Arthritis
A grant from the American College of Rheumatology (ACR)’s Rheumatology Research Foundation has helped Shiva Shahrara, PhD, conduct research into the molecule, IL-17, that plays a role in recruiting myeloid cells to migrate from the blood to the joint and perpetuating vascularization
A Spotlight on IgG4-Related Disease
What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)
ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?
Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit
Was Gout Rampant Among the Romans?
Lead in wine consumed by Romans may have contributed to a high incidence of gout among aristocrats of the Roman Empire
Rheumatology Drug Updates
Information on new approvals and medication safety rheumatologists need to know
What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)
Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
- « Previous Page
- 1
- …
- 112
- 113
- 114
- 115
- 116
- …
- 134
- Next Page »